0001543256-21-000001.txt : 20210114 0001543256-21-000001.hdr.sgml : 20210114 20210114164955 ACCESSION NUMBER: 0001543256-21-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210114 DATE AS OF CHANGE: 20210114 EFFECTIVENESS DATE: 20210114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immunomic Therapeutics, Inc. CENTRAL INDEX KEY: 0001543256 IRS NUMBER: 203878827 STATE OF INCORPORATION: DE FISCAL YEAR END: 1212 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-361369 FILM NUMBER: 21529410 BUSINESS ADDRESS: STREET 1: ATTN: WILLIAM HEARL, 15010 BROSCHART RD. STREET 2: SUITE 250 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-728-0860 MAIL ADDRESS: STREET 1: ATTN: WILLIAM HEARL, 15010 BROSCHART RD. STREET 2: SUITE 250 CITY: ROCKVILLE STATE: MD ZIP: 20850 D/A 1 primary_doc.xml X0708 D/A LIVE 0001543256 Immunomic Therapeutics, Inc. ATTN: WILLIAM HEARL, 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 301-728-0860 DELAWARE None None Corporation true WILLIAM G. HEARL 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Executive Officer Director Chief Executive Officer and Director C. ERIC WINZER 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Executive Officer Director Chief Financial Officer and Director MICHAEL D. LACK 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director JAMES W. WISHART 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director RONALD P. THIBOUTOT 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director YANG-GON JIN 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director HYUK JOO JEE 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director ARLO MCGINN 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director ALEX S KIM 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director Biotechnology Decline to Disclose 06b true 0001543256-20-000001 2020-02-18 false true true false 0 77728230 77728230 0 false 6 3109129 0 The individual also received warrants to purchase 621,826 shares at $5.00 per share. 0 false Immunomic Therapeutics, Inc. /s/ C. Eric Winzer C. Eric Winzer Chief Financial Officer 2021-01-14